| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |